Status:

UNKNOWN

Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia

Lead Sponsor:

Shalvata Mental Health Center

Conditions:

Schizophrenia

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Objectives:The purpose of the study is to explore the efficacy and safety of H1-Coil deep brain rTMS in subjects with negative symptoms and cognitive deficits of schizophrenia (deficit syndrome), curr...

Eligibility Criteria

Inclusion

  • Patients between the ages of 18-65 (male and female), Diagnosed in the past as suffering from schizophrenia. The diagnosis will be reaffirmed according to ICD criteria.
  • Right hand dominant.
  • Scores in PANSS negative questionnaire above 21.
  • Gave informed consent for participation in the study.
  • Negative answers on safety screening questionnaire for transcranial magnetic stimulation
  • stable on the same antipsychotic medication for at least two months prior to entering the study.
  • Negative answers to all questions in the TMS safety questionnaire (attached ).

Exclusion

  • Diagnosed as suffering from another axis 1 disorder .
  • Scores in PANSS positive questionnaire above 24.
  • History of epilepsy, seizure, or hot spasm.
  • History of epilepsy within first-degree relatives.
  • History of head injuries.
  • History of metal in the head (outside the mouth space).
  • History of surgery including metal implant or history of metal particles in the eye, pacemaker, or any other medical pump.
  • History of migraines.
  • History of hearing loss (not due to aging) or cochlear implants.
  • History of drug or alcohol abuse during the last year.
  • Women - Pregnancy or not using a reliable method of birth control.
  • Inability to achieve satisfying level of communication with the subject.
  • suicide attempt in the year prior to treatment or suicide risk according to a suicide questionnaire
  • Custodians.
  • Participation in another medical study during the experiment.

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2013

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT00685321

Start Date

June 1 2008

End Date

January 1 2013

Last Update

January 5 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Shalvata Mental Helath Center

Hod HaSharon, Israel

2

Shalvata

Hod HaSharon, Israel